Good morning, everyone. Hope you had a nice weekend. Now, of course, the routine resumes, although this is often a slow time of year. Nonetheless, there is much to be done here in the official Pharmalot c-suite, where we are catching up on interesting documents and conversations. And of course, we are brewing that mandatory cup of stimulation and invite you to join us. Meanwhile, here are a few tidbits from around the world. Hope your day goes well and you accomplish much...
Teva's Copaxone Successor Fails In Latest Clinical Trial (Bloomberg News)
Pfizer Says FDA Delays Prevnar Review For Three Months (Bloomberg News)
Cuba Sentences Pharma Execs For Corruption (Associated Press)
Japan's Shionogi Acquires C&O Pharmaceutical Tech (ChannelNewsAsia)
New FDA Commish Asks Congress For Additional Powers (Reuters)
Merck Shuts RNAi Research Center (Xconomy)
Lilly Wins Appeals Court Ruling In Strattera Patent Case (Bloomberg News)
Merck's Chief Strategy Officer Looks Back (The Star-Ledger of New Jersey)
Bristol-Myers Gets FDA OK For Subcutaneous Orencia (Reuters)
AmerisourceBergen Eyes M&A As Takeover War Chest Grows (Outsourcing Pharma)
EDITOR’S NOTE: Please check this post for updates throughout the morning
sunrise pic thx to benimoto on flickr
1 Comment
Morning!